EPO and Stroke: This concentration of the EPO was measured in cerebrospinal fluid (5.148 U/ml) of stroke patients after intravenous administration of 33,000 IE of human recombinant erythropoietin resulting in significant improvement of clinical outcome and neurological recovery [16].